Joy Birkelbach

Publication Activity (10 Years)

Years Active: 2022-2022
Publications (10 Years): 10

Top Topics

Silver Nanoparticles

Drug Administration

High Throughput

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Julian D Hegemann, Joy Birkelbach, Sebastian Walesch, Daniel Krug
Current developments in antibiotic discovery: Global microbial diversity as a source for evolutionary optimized anti-bacterials: Global microbial diversity as a source for evolutionary optimized anti-bacterials. EMBO reports 24 (1) (2022)
Sebastian Walesch, Joy Birkelbach, Gwenaëlle Jézéquel, F P Jake Haeckl, Julian D Hegemann, Thomas Hesterkamp, Anna Katharina Herta Hirsch, Peter Hammann, Daniel Krug
Fighting antibiotic resistance-strategies and (pre)clinical developments to find new antibacterials. EMBO reports (2022)
Julian D Hegemann, Joy Birkelbach, Sebastian Walesch, Daniel Krug
Current developments in antibiotic discovery: Global microbial diversity as a source for evolutionary optimized anti-bacterials: Global microbial diversity as a source for evolutionary optimized anti-bacterials. EMBO reports 24 (1) (2022)
Sebastian Walesch, Joy Birkelbach, Gwenaëlle Jézéquel, F P Jake Haeckl, Julian D Hegemann, Thomas Hesterkamp, Anna Katharina Herta Hirsch, Peter Hammann, Daniel Krug
Fighting antibiotic resistance-strategies and (pre)clinical developments to find new antibacterials. EMBO reports 24 (1) (2022)
Julian D Hegemann, Joy Birkelbach, Sebastian Walesch, Daniel Krug
Current developments in antibiotic discovery: Global microbial diversity as a source for evolutionary optimized anti-bacterials: Global microbial diversity as a source for evolutionary optimized anti-bacterials. EMBO reports (2022)
Julian D Hegemann, Joy Birkelbach, Sebastian Walesch, Daniel Krug
Current developments in antibiotic discovery: Global microbial diversity as a source for evolutionary optimized anti-bacterials: Global microbial diversity as a source for evolutionary optimized anti-bacterials. EMBO reports 24 (1) (2022)
Sebastian Walesch, Joy Birkelbach, Gwenaëlle Jézéquel, F P Jake Haeckl, Julian D Hegemann, Thomas Hesterkamp, Anna Katharina Herta Hirsch, Peter Hammann, Daniel Krug
Fighting antibiotic resistance-strategies and (pre)clinical developments to find new antibacterials. EMBO reports 24 (1) (2022)
Sebastian Walesch, Joy Birkelbach, Gwenaëlle Jézéquel, F P Jake Haeckl, Julian D Hegemann, Thomas Hesterkamp, Anna Katharina Herta Hirsch, Peter Hammann, Daniel Krug
Fighting antibiotic resistance-strategies and (pre)clinical developments to find new antibacterials. EMBO reports 24 (1) (2022)
Julian D Hegemann, Joy Birkelbach, Sebastian Walesch, Daniel Krug
Current developments in antibiotic discovery: Global microbial diversity as a source for evolutionary optimized anti-bacterials: Global microbial diversity as a source for evolutionary optimized anti-bacterials. EMBO reports 24 (1) (2022)
Sebastian Walesch, Joy Birkelbach, Gwenaëlle Jézéquel, F P Jake Haeckl, Julian D Hegemann, Thomas Hesterkamp, Anna Katharina Herta Hirsch, Peter Hammann, Daniel Krug
Fighting antibiotic resistance-strategies and (pre)clinical developments to find new antibacterials. EMBO reports 24 (1) (2022)